Location: San Francisco, CA
CIK: 0001844645 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 13, 2023
Total Value: $230M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | KARUNA THERAPEUTICS INC | 765,895 | $150M | 65.4% | $102.40 | — | COM | 48576A100 |
| PCVX | VAXCYTE INC | 693,039 | $33.23M | 14.5% | $37.18 | +5.6% | COM | 92243G108 |
| — | RALLYBIO CORP | 2,404,644 | $15.8M | 6.9% | $16.97 | — | COM | 75120L100 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 569,041 | $8.422M | 3.7% | $24.49 | -28.7% | COM | 03969K108 |
| — | VIGIL NEUROSCIENCE INC | 560,595 | $7.007M | 3.0% | $7.03 | — | COM | 92673K108 |
| — | FUSION PHARMACEUTICALS INC | 1,560,984 | $4.917M | 2.1% | $11.75 | — | COM | 36118A100 |
| — | EXSCIENTIA PLC | 772,285 | $4.116M | 1.8% | $19.76 | — | ADS | 30223G102 |
| — | INOZYME PHARMA INC | 2,661,154 | $2.794M | 1.2% | $14.26 | — | COM | 45790W108 |
| — | BOLT BIOTHERAPEUTICS INC | 1,891,467 | $2.459M | 1.1% | $32.91 | — | COM | 097702104 |
| — | ALIGOS THERAPEUTICS INC | 743,215 | $708K | 0.3% | $27.65 | — | COM | 01626L105 |